Sign in
TerminatedNo phase

Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry

Key facts

Who runs it
Gynesonics
Where
Germany, Switzerland, and United Kingdom9 sites in 3 countriesChoose a country to see its sites
Trial code
Status
Terminated
People taking part
182 people enrolled
Started
14 Jun 2017
Ended
11 Nov 2024
Type of study
Observational
Treatments tested
  • Sonata System
Record updated
16 December 2024
Why it stopped
Termination due to continued lack of patient compliance

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Have selected Sonata for treatment of symptomatic uterine fibroids or is participating in the OPEN study (Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids, NCT02844920, protocol # CL04897) or has completed participation in the OPEN study within the last 14 months
  • Speaks and reads a language for which questionnaires are available
  • Are greater than or equal to 18 years of age at the time of enrollment
  • Willing and able to read, understand and sign the informed consent form, to participate in the registry and to adhere to all registry study follow-up requirements

Who cannot take part

  • Any reason for which, in the opinion of the Investigator, the individual study patient is not appropriate or suitable for participation in the registry

This trial has no sites in United States.

It has sites in 3 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

SAGE is an observational post market registry with the objective of characterizing long term outcomes after treatment of uterine fibroids with the Sonata System in real world clinical practice settings.

The group in the trial

  • Sonata

    Women who undergo transcervical radiofrequency(RF) ablation with the Sonata System for treatment of their fibroids

    Treatment: Sonata System

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE)
Record updated
16 December 2024